FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/11/029318 [Registered on: 24/11/2020] Trial Registered Prospectively
Last Modified On: 09/11/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Other 
Public Title of Study   comparison between continuous infusion versus intermittent boluses of ropivacaine a local anaesthetic plus morphine in management of post operative pain after lower limb surgeries 
Scientific Title of Study   Comparison between epidural ropivacaine plus morphine intermittent boluses versus continuous infusion for post operative analgesia in lower limb surgery 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Avinash M 
Designation  Post Graduate 
Affiliation  Yenepoya University 
Address  Dept of Anaesthesiology Yenepoya medical college University Road, Deralakatte Mangalore

Dakshina Kannada
KARNATAKA
575018
India 
Phone  9886186186  
Fax    
Email  dravinashmunirathna@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shankara Narayana P 
Designation  Professor 
Affiliation  Yenepoya medical college and hospital 
Address  Dept of Anaesthesiology Yenepoya medical college University Road, Deralakatte Mangalore

Dakshina Kannada
KARNATAKA
575018
India 
Phone  7019293255  
Fax    
Email  drbhatta77@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Shankara Narayana P 
Designation  Professor 
Affiliation  Yenepoya medical college and hospital 
Address  Dept of Anaesthesiology Yenepoya medical college University Road, Deralakatte Mangalore

Dakshina Kannada
KARNATAKA
575018
India 
Phone  7019293255  
Fax    
Email  drbhatta77@yahoo.co.in  
 
Source of Monetary or Material Support  
Yenepoya medical college and hospital 
 
Primary Sponsor  
Name  Yenepoya Medical college  
Address  Department of anaesthesiology Yenepoya medical college University Road Deralakatte Mangalore 575018 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Avinash M  Yenepoya medical college  Dept of anaesthesiology Yenepoya medical college derelakatte mangalore
Dakshina Kannada
KARNATAKA 
9886186186

dravinashmunirathna@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Yenepoya Ethics Committee 2  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  continuous epidural infusion  50cc Infusion syringe with infusion pump containing ropivacaine 0.1%/ml and Morphine 1mg ( total of 50ml ) will be connected to the epidural catheter. The pump will be programmed with a continuous infusion of 6 mL/h flow  
Intervention  epidural bolus analgesia  Intermittent bolus with ropivacaine 0.1% and Morphine 1mg ( total of 50ml ) ,6mL bolus will be given every 60 min.infusion of 6 mL/h flow . 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients undergoing lower limb surgeries under spinal anaesthesia

ASA grade  1&2
 
 
ExclusionCriteria 
Details  Patient refusal
Hemodynamic instability
Patients with neuropathies
Patients on chronic analgesic therapy
Impaired higher mental function 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Intermittent boluses are similar to continuous infusion of epidural ropivacaine plus morphine for post operative analgesia.  12 hours 24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Early restoration and institution of physiotherapy
 
24 hours 48 hrs 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/11/2020 
Date of Study Completion (India) 01/11/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 01/11/2022 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Study Design

Quasi experimental study.

Materials and Methods

After obtaining the Ethical committee clearance, preparation of all participants will be done including written informed consent. Then participants will be divided into two groups:

Group IB        (intermittent bolus)

Group CI        (continuous infusion)

Source of data

Patients in Yenepoya Medical College Hospital, Deralakatte, Mangalore who are admitted in Dept. of .ORTHOPEDICS during the period of August 2020 to September 2020 undergoing elective lower limb surgeries

Sample Size :The sample size is calculated using G* Power software .

By considering level of significance at 10 % ( alpha = 0.10) and power 80 % with effect size 0.8(Standard Assumption) the total sample size in each group is 15 . Total size - 30

a) Sampling technique :Convenience sampling 

b) Details of Clinical Examination

Common procedure for both groups :

Patients (ASA classification 1 and 2) scheduled for elective lower limb surgeries will be counseled before surgery. In the operation theater, standard monitoring will be applied according to current ASA guidelines. Insertion of a lumbar epidural catheter (Perifix; B. Braun,) using a loss-of-resistance technique with Tuohy’s needle will be performed after skin disinfection in the sitting position at the L3-L4 or L2- L3 interspaces under mild sedation using 1-2 mg of intravenous (IV) midazolam. Following negative aspiration and negative response, a test dose of 3 mL of lidocaine 2% with epinephrine will be given. Spinal anaesthesia with Quincke’s 26G needle, following free flow of CSF,3 ml of 0.5% of hyperbaric bupivacaine will be injected into the sub arachnoid space. The indwelling catheter will be fixed using sterile dressing. After 5 min, cold/warm sensibility testing will be performed bilaterally to evaluate the appropriate spread. After surgery, patients will be transferred to the post-anaesthesia care unit (PACU)

Intervention in individual groups :

Group CI:

50cc Infusion syringe with infusion pump containing ropivacaine 0.1%/ml and Morphine 1mg ( total of  50ml ) will be connected to the epidural catheter. The pump will be programmed with a continuous infusion of 6 mL/h flow .

Group IB:

Intermittent bolus with ropivacaine 0.1% and Morphine 1mg ( total of  50ml ) ,6mL bolus will be  given every 60 min.

For both groups epidural analgesia will be started once the patient starts complaining of pain or VAS score more than 4 .

In case of insufficient analgesic response, controlled bolus injection of 4 mL (with lockout time: 30 min) will be given if the VAS score is more than 4. IV rescue analgesia with Inj tramadol 50 mg intravenously will be allowed as a ’rescue option’ for all participants in both groups.

As adverse effects there might be a fall in Blood pressure during epidural bolus injection which will be continuously monitored and taken care by immediately stopping the infusion or bolus and if required Inj Ephedrine 3mg iv is given to stabilize the BP . In very few patients there can be mild breathing difficulties which is temporary and very rarely needs support, otherwise no other adverse effects will be present.

The patients will be followed up at 12th& 24th hour interval. Pain assessment will be done by a 10 cm visual analogue scale (VAS); 0 no pain 10 worst imaginable pain. Change in heart rate and blood pressure will also be monitored. Patients will be reassessed and monitored for any side effects like nausea, vomiting, gastric irritation and respiratory depression every 30 minutes

c) Details of study like questionnaire

Whether the participant is experiencing any pain postoperatively and rate the pain according to picture scale from 10 –1, heart rate and blood pressure monitoring

d) Validation of study tool (if applicable)  -----Nil-----

e)Details of investigations (if any) and how the sample will be obtained and processed. -----Nil----


Details of data tabulation and statistical analysis to be employed

Statistical analysis : Descriptive statistics

Independent sample t test/ mann whitney u test will be employed to find out the mean difference in the analgesia achieved between 2 groups.

 
Close